The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
Three major drugmakers recently announced refunds for 340B covered entities that purchased certain drugs in 2022 and 2023 following recalculations [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key health policy staffer for U.S. Senate Health, Education, Labor and Pensions (HELP) Committee Chairman Bill Cassidy (R-La.) recently [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers recently added new medications to the list of drugs subject to their respective 340B contract pharmacy restrictions—one of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major group purchasing organization (GPO) recently urged a Washington D.C. federal court to reject the federal government’s defense of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
340B stakeholders and attorneys offered mixed initial reactions this week to President Donald Trump’s proposal to move the 340B program [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Trump administration adviser and key figure in a dark money effort to tie the 340B program to immigration growth, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key U.S. senator on 340B policy continued to raise concerns this week about the current state of the drug [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...] …